Role of liver function tests among pregnant women with respect to feto-maternal outcome in third trimester: an analytical cross-sectional study

Sapna Singh; Priyanka Yadav; Pavika Lal; Pratima Verma

doi:10.18203/2320-1770.ijrcog20250519

Authors

Sapna Singh Department of Obstetrics and Gynecology, GSVM Medical College, Kanpur, Uttar Pradesh, India
Priyanka Yadav Department of Obstetrics and Gynecology, GSVM Medical College, Kanpur, Uttar Pradesh, India
Pavika Lal Department of Obstetrics and Gynecology, GSVM Medical College, Kanpur, Uttar Pradesh, India
Pratima Verma Department of Obstetrics and Gynecology, GSVM Medical College, Kanpur, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20250519

Keywords:

HELLP syndrome, Hyperemesis gravidarum, Intrahepatic cholestasis of pregnancy, Preeclampsia

Abstract

Background: Liver disease occurs in approximately 3% of pregnant women so it has adverse effect on feto-maternal outcome. Diseases specifically related to pregnancy are intra-hepatic cholestasis of pregnancy, acute fatty liver of pregnancy, abnormal liver function with preeclampsia, HELLP syndrome and hyperemesis gravidarum. Aim was to determine prevalence of liver disease in pregnancy and the impact of abnormal liver function tests on feto-maternal outcome

Methods: It was an analytical cross-sectional study conducted in the department of obstetrics and gynecology, UISEMH, GSVM Medical College, Kanpur for a period of 2 years. All antenatal patients between the ages of 18-40 years who presented with abnormal liver function tests in third trimester were enrolled. Socio demographic and detailed clinical history was taken from all such patients and they were followed till delivery for feto-maternal outcome.

Results: Hypertensive disorders in pregnancy were the most common cause of abnormal liver function tests in pregnancy (55.25%), followed by intrahepatic cholestasis in pregnancy (23.91%). Acute viral hepatitis was present in 8% patients. In 39% patients, preterm delivery was documented about 43.7% babies had birth weight less than 2.5 kg. Maternal mortality was 15.3% and perinatal mortality was 24.7%.

Conclusions: Deranged liver function in pregnancy is associated with significant maternal and perinatal morbidity. Early diagnosis and appropriate intervention can improve feto-maternal outcome.

Metrics

Metrics Loading ...

References

Ch’ng CL, Morgan M, Hainsworth I, Kingham JG. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut. 2002;51:876-80. DOI: https://doi.org/10.1136/gut.51.6.876

Joshi D, James A, Quaglia A, Westbrook RH, Heneghan MA. Liver disease in pregnancy. Lancet. 2010;375:594-605. DOI: https://doi.org/10.1016/S0140-6736(09)61495-1

Ellington SR, Flowers L, Legardy-Williams JK, Jamieson DJ, Kourtis AP. Recent trends in hepatic diseases during pregnancy in the United States, 2002-2010. Am J Obstet Gynecol. 2015;212:524.e1-7. DOI: https://doi.org/10.1016/j.ajog.2014.10.1093

Allen AM, Kim WR, Larson JJ, Rosedahl JK, Yawn BP, McKeon K, et al. The epidemiology of liver diseases unique to pregnancy in a US community: a population-based study. Clin Gastroenterol Hepatol. 2016;14:287-94.e1-2. DOI: https://doi.org/10.1016/j.cgh.2015.08.022

Westbrook RH, Dusheiko G, Williamson C. Pregnancy and liver disease. J Hepatol. 2016;64:933-45. DOI: https://doi.org/10.1016/j.jhep.2015.11.030

Mikolasevic I, Filipec-Kanizaj T, Jakopcic I, Majurec I, Brncic-Fischer A, Sobocan N, et al. Liver disease during pregnancy: a challenging clinical issue. Med Sci Monit. 2018;24:4080-90. DOI: https://doi.org/10.12659/MSM.907723

Patra K, Chattopadhyay S, Bisbas S. A study of abnormal liver function test in pregnant women and its correlation with fetomaternal outcome in a teaching hospital Kolkata, eastern India. Asian J Med Sci. 2022;13(8). DOI: https://doi.org/10.3126/ajms.v13i8.44879

Jhirwal M, Sharma C, Singh P. Maternal and perinatal outcome in pregnancy complicated by intrahepatic cholestasis. Cureus. 2022;14(8). DOI: https://doi.org/10.7759/cureus.28512

Vinayachandran SN, Anaswara K. Liver disorders in pregnancy: a fetomaternal outcome. J South Asian Feder Obst Gynaecol. 2020;12(3):167-71. DOI: https://doi.org/10.5005/jp-journals-10006-1788

Tripathi R, Brahmane M, Jain SB. Effect of abnormal liver function test on maternal and perinatal outcome in pregnancy: observational study. Int J Reprod Contracept Obstet Gynecol. 2020;9(10):4063-7. DOI: https://doi.org/10.18203/2320-1770.ijrcog20204288

Johnson KD, Perisetti A, Thandassery R, Inamdar S, Cheryala M, Jecmenica M, et al. Laboratory evaluation of deranged liver chemistries in pregnancy. J Lab Precis Med. 2020;5. DOI: https://doi.org/10.21037/jlpm.2019.10.05

García-Romero CS, Guzman C, Cervantes A, Cerbón M. L. Liver disease in pregnancy: Medical aspects and their implications for mother and child. Ann Hepatol. 2019;18:553-62. DOI: https://doi.org/10.1016/j.aohep.2019.04.009

Von Dadelszen P, Magee LA, Devarakonda RM, Hamilton T, Ainsworth LM, Yin R, et al. The predictors of adverse maternal outcomes in preeclampsia. J Obstet Gynecol Can. 2004;26:871. DOI: https://doi.org/10.1016/S1701-2163(16)30137-2

Changede P, Chavan N, Raj N. An observational study to evaluate the maternal and foetal outcomes in pregnancies complicated with jaundice. The J Obstet Gynecol India. 2019;69(1):31-6. DOI: https://doi.org/10.1007/s13224-018-1105-9

Mutua DN, MwanikiNjagi EN, Orinda G. Liver Function Tests in Normal Pregnant Women. J Liver. 2018;7:228.

Sumangali PK, Kurian S. Study of abnormal liver function tests in pregnancy in a tertiary centre in north Kerala. Int J Res Med Sci. 2017;5:5193-6. DOI: https://doi.org/10.18203/2320-6012.ijrms20175118

Choudhary N, Sen S, Varalakshmi K. A prospective study on pregnancy complicated with jaundice with special emphasis on fetomaternal outcome. Int J Reprod Contracept Obstet Gynecol. 2017;6(11):5081-8. DOI: https://doi.org/10.18203/2320-1770.ijrcog20175029

Tiwari A, Aditya V, Srivastava R. Study of spectrum and outcome of liver diseases in pregnant women at BRD medical college Int J Reprod Contracept Obstet Gynecol. 2017;6(8):3641-5. DOI: https://doi.org/10.18203/2320-1770.ijrcog20173501

Mishra N, Mishra VN, Thakur P. Study of abnormal liver function test during pregnancy in a tertiary care hospital in Chhattisgarh. J Obstet Gynecol India. 2016;66(1):129-35. DOI: https://doi.org/10.1007/s13224-015-0830-6

Kozic JR, Benton SJ, Hutcheon JA, Payne BA, Magee LA, von Dadelszen P. Abnormal liver function tests as predictors of adverse maternal outcomes in women with preeclampsia. J Obstet Gynaecol Canada. 2011;33(10):995-1004. DOI: https://doi.org/10.1016/S1701-2163(16)35048-4

Rathi U, Bapat M, Rathi P, Abraham P. Effect of liver disease on maternal and fetal outcome-a prospective study. Ind J Gastroenterol. 2007;26(2):59.

Singhal S, Deepika A, Nanda S. Maternal and perinatal outcome in severe pre-eclampsia and eclampsia. South Asian Feder Obstet Gynecol. 2009;1(3):25-8. DOI: https://doi.org/10.5005/jp-journals-10006-1005

Kumar S, Bansal D, Hota D, Jain M, Singh P, Pandey BL. Assessment of clinical outcomes and prescribing behavior among inpatients with severe preeclampsia and eclampsia: an Indian experience. Indian J Pharmacol. 2014;46(1):18. DOI: https://doi.org/10.4103/0253-7613.125159